- Home
- CRNX vs SPNT Comparison
CRNX vs SPNT Comparison
Compare CRNX & SPNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRNX
- SPNT
- Stock Information
- Founded
- CRNX 2008
- SPNT 2011
- Country
- CRNX United States
- SPNT Bermuda
- Employees
- CRNX N/A
- SPNT N/A
- Industry
- CRNX Biotechnology: Pharmaceutical Preparations
- SPNT Property-Casualty Insurers
- Sector
- CRNX Health Care
- SPNT Finance
- Exchange
- CRNX Nasdaq
- SPNT Nasdaq
- Market Cap
- CRNX 2.8B
- SPNT 2.2B
- IPO Year
- CRNX 2018
- SPNT N/A
- Fundamental
- Price
- CRNX $30.16
- SPNT $19.28
- Analyst Decision
- CRNX Strong Buy
- SPNT Hold
- Analyst Count
- CRNX 10
- SPNT 1
- Target Price
- CRNX $75.00
- SPNT $17.00
- AVG Volume (30 Days)
- CRNX 676.7K
- SPNT 525.3K
- Earning Date
- CRNX 08-07-2025
- SPNT 07-31-2025
- Dividend Yield
- CRNX N/A
- SPNT N/A
- EPS Growth
- CRNX N/A
- SPNT N/A
- EPS
- CRNX N/A
- SPNT 0.96
- Revenue
- CRNX $760,000.00
- SPNT $2,682,300,000.00
- Revenue This Year
- CRNX $402.12
- SPNT $11.96
- Revenue Next Year
- CRNX $770.88
- SPNT $6.66
- P/E Ratio
- CRNX N/A
- SPNT $20.13
- Revenue Growth
- CRNX N/A
- SPNT N/A
- 52 Week Low
- CRNX $24.10
- SPNT $11.96
- 52 Week High
- CRNX $62.53
- SPNT $20.00
- Technical
- Relative Strength Index (RSI)
- CRNX 41.11
- SPNT 52.99
- Support Level
- CRNX $32.05
- SPNT $18.96
- Resistance Level
- CRNX $31.56
- SPNT $20.00
- Average True Range (ATR)
- CRNX 1.08
- SPNT 0.51
- MACD
- CRNX -0.18
- SPNT -0.09
- Stochastic Oscillator
- CRNX 5.25
- SPNT 44.62
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.
About SPNT SiriusPoint Ltd.
SiriusPoint Ltd provides property and casualty reinsurance coverage to insurance and reinsurance companies in the United States, Canada, Bermuda, the United Kingdom, and Europe. The company operates through two operating segments: Reinsurance and Insurance & Services. The company's product portfolio consists of reinsurance contracts for property insurance including both residential and commercial properties, workers' compensation, personal automobile, businesses' general liability insurance, professional liability insurance to protect professional advisors and service providers, agriculture insurance, and mortgage insurance. The majority of the revenue is generated from its Insurance & Services segment.